docetaxel anhydrous has been researched along with Lymphatic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, YS; Kang, JH; Kim, GY; Lee, KS; Lee, MA; Shim, KH; Woo, IS | 1 |
1 other study(ies) available for docetaxel anhydrous and Lymphatic Diseases
| Article | Year |
|---|---|
Nail changes during docetaxel containing combination chemotherapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lymphatic Diseases; Middle Aged; Nail Diseases; Stomach Neoplasms; Taxoids | 2004 |